ID

43867

Description

Synergistic Treatment for Hepatocellular Carcinoma (HCC) Using TACE With Antiangiogenesis; ODM derived from: https://clinicaltrials.gov/show/NCT00518557

Link

https://clinicaltrials.gov/show/NCT00518557

Keywords

Versions (2)
  1. 6/27/17 6/27/17 -
  2. 9/20/21 9/20/21 -
Uploaded on

September 20, 2021

DOI

To request one please log in.

License

Creative Commons BY 4.0
Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Back to model comments
Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Eligibility Hepatocellular Carcinoma NCT00518557

English

Eligibility Hepatocellular Carcinoma NCT00518557

1 forms  
Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
patients with cytologically or histologically documented hcc, who are candidates for tace
Description

ID.1

Data type

boolean

Alias
UMLS CUI [1,1]
C2239176
UMLS CUI [1,2]
C3539919
child-pugh child a or b
Description

ID.2

Data type

boolean

Alias
UMLS CUI [1]
C4050412
age >= 18
Description

ID.3

Data type

boolean

Alias
UMLS CUI [1]
C0001779
measurable disease by recist criteria;
Description

ID.4

Data type

boolean

Alias
UMLS CUI [1]
C1709926
performance status ecog 0-2
Description

ID.5

Data type

boolean

Alias
UMLS CUI [1]
C1520224
previous local therapy completed > 4 weeks
Description

ID.6

Data type

boolean

Alias
UMLS CUI [1]
C1517925
written informed consent signed
Description

ID.7

Data type

boolean

Alias
UMLS CUI [1]
C0021430
normal organ and marrow function defined as:
Description

ID.8

Data type

boolean

Alias
UMLS CUI [1]
C0678852
wbc ≥ 3,000/µl platelet count > 80,000/mm3
Description

ID.10

Data type

boolean

Alias
UMLS CUI [1,1]
C0018957
UMLS CUI [1,2]
C0023516
UMLS CUI [1,3]
C0032181
haemoglobin > 9g/dl
Description

ID.11

Data type

boolean

Alias
UMLS CUI [1]
C0019046
hepatic: albumin ≥ 2.8 g/dl. serum total bilirubin ≤ 3 mg/dl; ast or alt < 5 x uln
Description

ID.12

Data type

boolean

Alias
UMLS CUI [1,1]
C0201838
UMLS CUI [1,2]
C1278039
UMLS CUI [1,3]
C0004002
UMLS CUI [1,4]
C0001899
renal: creatinine < 1.5 x uln
Description

ID.13

Data type

boolean

Alias
UMLS CUI [1]
C0010294
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
metastases
Description

ID.14

Data type

boolean

Alias
UMLS CUI [1]
C0027627
prior or concomitant chemotherapy or radiation therapy
Description

ID.15

Data type

boolean

Alias
UMLS CUI [1]
C3178775
vegf/vegfr- inhibitors or other anti-angiogenesis agents
Description

ID.16

Data type

boolean

Alias
UMLS CUI [1]
C1257849
severe and/or uncontrolled medical conditions:
Description

ID.17

Data type

boolean

Alias
UMLS CUI [1]
C0012634
congestive heart failure, serious cardiac arrhythmia, active coronary artery
Description

ID.18

Data type

boolean

Alias
UMLS CUI [1]
C0018799
severe renal impairment
Description

ID.19

Data type

boolean

Alias
UMLS CUI [1]
C0022658
patients who anticipate receiving major surgery during the course of the
Description

ID.20

Data type

boolean

Alias
UMLS CUI [1]
C0679637
pregnant or breastfeeding patients
Description

ID.21

Data type

boolean

Alias
UMLS CUI [1,1]
C0032961
UMLS CUI [1,2]
C0006147
evidence of bleeding diathesis
Description

ID.22

Data type

boolean

Alias
UMLS CUI [1]
C0005779
Back to the top of the page

Similar models

Eligibility Hepatocellular Carcinoma NCT00518557

1 forms
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
C1512693 (UMLS CUI)
ID.1
Item
patients with cytologically or histologically documented hcc, who are candidates for tace
boolean
C2239176 (UMLS CUI [1,1])
C3539919 (UMLS CUI [1,2])
ID.2
Item
child-pugh child a or b
boolean
C4050412 (UMLS CUI [1])
ID.3
Item
age >= 18
boolean
C0001779 (UMLS CUI [1])
ID.4
Item
measurable disease by recist criteria;
boolean
C1709926 (UMLS CUI [1])
ID.5
Item
performance status ecog 0-2
boolean
C1520224 (UMLS CUI [1])
ID.6
Item
previous local therapy completed > 4 weeks
boolean
C1517925 (UMLS CUI [1])
ID.7
Item
written informed consent signed
boolean
C0021430 (UMLS CUI [1])
ID.8
Item
normal organ and marrow function defined as:
boolean
C0678852 (UMLS CUI [1])
ID.10
Item
wbc ≥ 3,000/µl platelet count > 80,000/mm3
boolean
C0018957 (UMLS CUI [1,1])
C0023516 (UMLS CUI [1,2])
C0032181 (UMLS CUI [1,3])
ID.11
Item
haemoglobin > 9g/dl
boolean
C0019046 (UMLS CUI [1])
ID.12
Item
hepatic: albumin ≥ 2.8 g/dl. serum total bilirubin ≤ 3 mg/dl; ast or alt < 5 x uln
boolean
C0201838 (UMLS CUI [1,1])
C1278039 (UMLS CUI [1,2])
C0004002 (UMLS CUI [1,3])
C0001899 (UMLS CUI [1,4])
ID.13
Item
renal: creatinine < 1.5 x uln
boolean
C0010294 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
ID.14
Item
metastases
boolean
C0027627 (UMLS CUI [1])
ID.15
Item
prior or concomitant chemotherapy or radiation therapy
boolean
C3178775 (UMLS CUI [1])
ID.16
Item
vegf/vegfr- inhibitors or other anti-angiogenesis agents
boolean
C1257849 (UMLS CUI [1])
ID.17
Item
severe and/or uncontrolled medical conditions:
boolean
C0012634 (UMLS CUI [1])
ID.18
Item
congestive heart failure, serious cardiac arrhythmia, active coronary artery
boolean
C0018799 (UMLS CUI [1])
ID.19
Item
severe renal impairment
boolean
C0022658 (UMLS CUI [1])
ID.20
Item
patients who anticipate receiving major surgery during the course of the
boolean
C0679637 (UMLS CUI [1])
ID.21
Item
pregnant or breastfeeding patients
boolean
C0032961 (UMLS CUI [1,1])
C0006147 (UMLS CUI [1,2])
ID.22
Item
evidence of bleeding diathesis
boolean
C0005779 (UMLS CUI [1])
Back to the top of the page 

Contact

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial